{"title": "Evidenz der Komplement\u00e4rmedizin am Beispiel Integrative Onkologie", "author": "SAEZ Schweizerische \u00c4rztezeitung; Florian Strasser", "url": "https://saez.swisshealthweb.ch/de/article/doi/saez.2023.21921", "hostname": "swisshealthweb.ch", "description": null, "sitename": "Florian Strasser", "date": "2023-06-14", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "1 Paterson C, Toohey K, Bacon R, Kavanagh PS, Roberts C. What Are the Unmet Supportive Care Needs of People Affected by Cancer: An Umbrella Systematic Review. Semin Oncol Nurs 2022:151353.\n2 Shneerson C, Taskila T, Holder R, Greenfield S, Tolosa I, Damery S, Gale N. Patterns of self-management practices undertaken by cancer survivors: variations in demographic factors. Eur J Cancer Care (Engl) 2015;24(5):683-94.\n3 Boland L, Bennett K, Connolly D. Self-management interventions for cancer survivors: a systematic review. Support Care Cancer 2018;26(5):1585-1595.\n4 Kemppainen LM, et al. Use of complementary and alternative medicine in Europe: Health-related and sociodemographic determinants. Scand J Public Health 2018;46(4):448-455.\n5 Wode K, Henriksson R, Sharp L, Stoltenberg A, H\u00f6k Nordberg J. Cancer patients\u2019 use of complementary and alternative medicine in Sweden: a cross-sectional study. BMC Complement Altern Med 2019;19(1):62.\n6 Khatib R, Lee GA, Marques-Sule E, et al. Evaluating the extent of patient-centred care in a selection of ESC guidelines. Eur Heart J Qual Care Clin Outcomes 2020;6(1):55-61. doi: 10.1093/ehjqcco/qcz025.\n7 Fritzen K, Stautner C, Schnell O. Patient-centred care in type 2 diabetes mellitus \u2013 Key aspects of PDM-ProValue are reflected in the 2018 ADA/EASD consensus report. Diabetes Res Clin Pract 2019;158:107897. doi:\n[10.1016/j.diabres.2019.107897](https://pubmed.ncbi.nlm.nih.gov/31672502/)\n.\n8 Brunelli A, Blackmon SH, Sent\u00fcrk M, et al. Patient-centred care in thoracic surgery: a holistic approach \u2013 A review of the subjects of enhanced recovery after surgery, rehabilitation, pain management and patient-reported outcome measures in thoracic surgery. J Thorac Dis 2022;14(2):546-552.\n[doi: 10.21037/jtd-21-1763](https://pubmed.ncbi.nlm.nih.gov/35280471/)\n.\n9 Jordan K, Aapro M, Kaasa S, Ripamonti CI, Scott\u00e9 F, Strasser F, Young A, Bruera E, Herrstedt J, Keefe D, Laird B, Walsh D, Douillard JY, Cervantes A. European Society for Medical Oncology (ESMO) position paper on supportive and palliative care. Ann Oncol 2018;29(1):36-43.\n10 Vehling S, Kissane DW. Existential distress in cancer: Alleviating suffering from fundamental loss and change. Psychooncology 2018;27(11):2525-2530.\n11 Harnischfeger N, Rath HM, Alt-Epping B, Brand H, Haller K, Letsch A, Rieder N, Thuss-Patience P, Bokemeyer C, Bergelt C, Oechsle K. Effects of a communication training for oncologists on early addressing palliative and end-of-life care in advanced cancer care (PALLI-COM): a randomized, controlled trial. ESMO Open 2022;7(6):100623.\n12 Chochinov HM. Intensive Caring: Reminding Patients They Matter. J Clin Oncol 2023; Apr 19:JCO2300042.\n13 Ribi K, Kalbermatten N, Eicher M, Strasser F. Towards a novel approach guiding the decision-making process for anticancer treatment in patients with advanced cancer: framework for systemic anticancer treatment with palliative intent. ESMO Open 2022;7(3):100496.\n14 Garc\u00eda-Chico C, L\u00f3pez-Ortiz S, Pe\u00f1\u00edn-Grandes S, Pinto-Fraga J, Valenzuela PL, Emanuele E, Ceci C, Graziani G, Fiuza-Luces C, Lista S, Lucia A, Santos-Lozano A. Physical Exercise and the Hallmarks of Breast Cancer: A Narrative Review. Cancers (Basel) 2023;15(1):324.\n15 Cheng E, Ou FS, Ma C, Spiegelman D, Zhang S, Zhou X, Bainter TM, Saltz LB, Niedzwiecki D, Mayer RJ, Whittom R, Hantel A, Benson A, Atienza D, Messino M, Kindler H, Giovannucci EL, Van Blarigan EL, Brown JC, Ng K, Gross CP, Meyerhardt JA, Fuchs CS. Diet- and Lifestyle-Based Prediction Models to Estimate Cancer Recurrence and Death in Patients With Stage III Colon Cancer (CALGB 89803/Alliance). J Clin Oncol 2022;40(7):740-751.\n16 McCusker J, Jones JM, Li M, Faria R, Yaffe MJ, Lambert SD, Ciampi A, Belzile E, de Raad M. CanDirect: Effectiveness of a Telephone-Supported Depression Self-Care Intervention for Cancer Survivors. J Clin Oncol 2021;39(10):1150-1161.\n17 Fann JR, Hong F, Halpenny B, Blonquist TM, Berry DL. Psychosocial outcomes of an electronic self-report assessment and self-care intervention for patients with cancer: a randomized controlled trial. Psychooncology 2017;26(11):1866-1871.\n18 Gr\u00e9goire C, Faymonville ME, Vanhaudenhuyse A, Charland-Verville V, Jerusalem G, Willems S, Bragard I. Effects of an intervention combining self-care and self-hypnosis on fatigue and associated symptoms in post-treatment cancer patients: A randomized-controlled trial. Psychooncology.2020;29(7):1165-1173.\n19 Ot\u00e1lora-Ot\u00e1lora BA, L\u00f3pez-Kleine L, Rojas A. Lung Cancer Gene Regulatory Network of Transcription Factors Related to the Hallmarks of Cancer. Curr Issues Mol Biol 2023;45(1):434-464.\n20 Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med 2015;372(9):793-5.\n21 Hanahan D. Hallmarks of Cancer: New Dimensions. Cancer Discov 2022;12(1):31-46.\n22 Qian DC, Kleber T, Brammer B, Xu KM, Switchenko JM, Janopaul-Naylor JR, Zhong J, Yushak ML, Harvey RD, Paulos CM, Lawson DH, Khan MK, Kudchadkar RR, Buchwald ZS. Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study. Lancet Oncol 2021;22(12):1777-1786.\n23 Wang C, Barnoud C, Cenerenti M, Sun M, Caffa I, Kizil B, Bill R, Liu Y, Pick R, Garnier L, Gkountidi OA, Ince LM, Holtkamp S, Fournier N, Michielin O, Speiser DE, Hugues S, Nencioni A, Pittet MJ, Jandus C, Scheiermann C. Dendritic cells direct circadian anti-tumour immune responses. Nature 2023;614(7946):136-143.\n24 Griffin ME, Espinosa J, Becker JL, Luo JD, Carroll TS, Jha JK, Fanger GR, Hang HC. Enterococcus peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapy. Science 2021;373(6558):1040-1046.\n25 Sbierski-Kind J, Grenkowitz S, Schlickeiser S, Sandforth A, Friedrich M, Kunkel D, Glauben R, Brachs S, Mai K, Th\u00fcrmer A, Radoni\u0107 A, Drechsel O, Turnbaugh PJ, Bisanz JE, Volk HD, Spranger J, von Schwartzenberg RJ. Effects of caloric restriction on the gut microbiome are linked with immune senescence. Microbiome 2022;10(1):57.\n26 Kienle GS, Glockmann A, Grugel R, Hamre HJ, Kiene H. Klinische Forschung zur Anthroposophischen Medizin \u2013 update eines \u00abHealth Technology Assessment\u00bb-Berichts und status quo [Clinical research on anthroposophic medicine:update of a health technology assessment report and status quo]. Forsch Komplementmed 2011;18(5):269-82.\n27 Ulrich Meyer. \u00abStudieren Sie den Rhythmus. Rhythmus tr\u00e4gt Leben.\u00bb \u2013 Das Gespr\u00e4ch Steiner/Hauschka im Kontext der Arnheimer Vortr\u00e4ge 1924. Der Merkurstab 2008;61(3):263-269.\n28 Vagedes J, Fazeli A, Boening A, Helmert E, Berger B, Martin D. Efficacy of rhythmical massage in comparison to heart rate variability biofeedback in patients with dysmenorrhea-A randomized, controlled trial. Complement Ther Med 2019;42:438-444.\n29 Edelh\u00e4user F, Minnerop A, Trapp B, B\u00fcssing A, Cysarz D. Eurythmy therapy increases specific oscillations of heart rate variability. BMC Complement Altern Med 2015;15:167.\n30 Meier-Girard D, Ribi K, Gerstenberg G, Ruhstaller T, Wolf U. Eurythmy therapy versus slow movement fitness in the treatment of fatigue in metastatic breast cancer patients: study protocol for a randomized controlled trial. Trials 2020;21(1):612.\n32 Huang N, Chelliah Y, Shan Y, Taylor CA, Yoo SH, Partch C, Green CB, Zhang H, Takahashi JS. Crystal structure of the heterodimeric CLOCK:BMAL1 transcriptional activator complex. Science 2012;337(6091):189-94.\n33 Muraro E, Vinante L, Fratta E, Bearz A, H\u00f6fler D, Steffan A, Baboci L. Metronomic Chemotherapy: Anti-Tumor Pathways and Combination with Immune Checkpoint Inhibitors. Cancers (Basel) 2023;15(9):2471.\n34 Verlande A, Masri S. Circadian Clocks and Cancer: Timekeeping Governs Cellular Metabolism. Trends Endocrinol Metab 2019;30(7):445-458.\n35 Conaway S Jr, Nayak AP, Deshpande DA. Therapeutic potential and challenges of bitter taste receptors on lung cells. Curr Opin Pharmacol 2020;51:43-49.\n36 Carey RM, Kim T, Cohen NA, Lee RJ, Nead KT. Impact of sweet, umami, and bitter taste receptor (TAS1R and TAS2R) genomic and expression alterations in solid tumors on survival. Sci Rep 2022;12(1):8937.\n37 Kanherkar RR, Stair SE, Bhatia-Dey N, Mills PJ, Chopra D, Csoka AB. Epigenetic Mechanisms of Integrative Medicine. Evid Based Complement Alternat Med 2017;2017:4365429.\n38 McEwen BS. Integrative medicine: Breaking down silos of knowledge and practice an epigenetic approach. Metabolism 2017;69S:S21-S29.\n39 Sbierski-Kind J, Grenkowitz S, Schlickeiser S, Sandforth A, Friedrich M, Kunkel D, Glauben R, Brachs S, Mai K, Th\u00fcrmer A, Radoni\u0107 A, Drechsel O, Turnbaugh PJ, Bisanz JE, Volk HD, Spranger J, von Schwartzenberg RJ. Effects of caloric restriction on the gut microbiome are linked with immune senescence. Microbiome 2022;10(1):57.\n40 Deng C, Xie Y, Liu Y, Li Y, Xiao Y. Aromatherapy Plus Music Therapy Improve Pain Intensity and Anxiety Scores in Patients With Breast Cancer During Perioperative Periods: A Randomized Controlled Trial. Clin Breast Cancer 2022;22(2):115-120.\n41 Wode K, H\u00f6k Nordberg J, Kienle GS, Elander NO, Bernhardson BM, Sunde B, Sharp L, Henriksson R, Fransson P. Efficacy of mistletoe extract as a complement to standard treatment in advanced pancreatic cancer: study protocol for a multicentre, parallel group, double-blind, randomised, placebo-controlled clinical trial (MISTRAL). Trials 2020;21(1):783.\n42 Paller CJ, Wang L, Fu W, Kumar R, Durham JN, Azad NS, Laheru DA, Browner I, Kachhap SK, Boyapati K, Odeny T, Armstrong DK, Meyer CF, Gaillard S, Brahmer JR, Page I, Wang H, Diaz LA Jr. Phase I Trial of Intravenous Mistletoe Extract in Advanced Cancer. Cancer Res Commun 2023;3(2):338-346.\n43 Huber C, Zhang L, Schlaeppi M, M\u00fcller T, Roll S, Voiss P, Barth J, Driessen C, Witt CM. Acupuncture in chemotherapy-induced dysgeusia (AcuDysg): study protocol of a randomised controlled trial. BMJ Open 2023;13(3):e06613.\n44 Kr\u00f6z M, Quittel F, Reif M, Zerm R, Pranga D, Bartsch C, Brinkhaus B, B\u00fcssing A, Gutenbrunner C; CRF study group. Four-year follow-up on fatigue and sleep quality of a three-armed partly randomized controlled study in breast cancer survivors with cancer-related fatigue. Sci Rep 2023;13(1):2705.\n45 Kr\u00f6z M, Reif M, Glinz A, Berger B, Nikolaou A, Zerm R, Brinkhaus B, Girke M, B\u00fcssing A, Gutenbrunner C; CRF-2 study group. Impact of a combined multimodal-aerobic and multimodal intervention compared to standard aerobic treatment in breast cancer survivors with chronic cancer-related fatigue - results of a three-armed pragmatic trial in a comprehensive cohort design. BMC Cancer 2017;17(1):166. doi: 10.1186/s12885-017-3142-7.\n46 Hamre HJ, Kiene H, Ziegler R, et al. Overview of the Publications From the Anthroposophic Medicine Outcomes Study (AMOS): A Whole System Evaluation Study. Glob Adv Health Med 2014;3(1):54-70. doi: 10.7453/gahmj.2013.010.\n47 Heusser P. Anthroposophie und Wissenschaft. Eine Einf\u00fchrung. Verlag am Goetheanum, 2016. ISBN 978-3-7235-1568-6.\n48 Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn\u2019t. BMJ 1996;312(7023):71-2. doi: 10.1136/bmj.312.7023.71.\n51 Straus SE, Glasziou P, Richardson WS, Haynes RB. Evidence-based medicine: how to practice and teach EBM. Elsevier, 5. Edition, 2018.\n52 Kumaravel B, Hearn JH, Jahangiri L, Pollard R, Stocker CJ, Nunan D. A systematic review and taxonomy of tools for evaluating evidence-based medicine teaching in medical education. Syst Rev 2020;9(1):91.\n[doi: 10.1186/s13643-020-01311-y](https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-020-01311-y)\n.\n53 Simons M, Rapport F, Zurynski Y, et al. Links between evidence-based medicine and shared decision-making in courses for doctors in training: a scoping review. BMJ Open 2022;12(4):e057335.\n[doi: 10.1136/bmjopen-2021-057335](https://bmjopen.bmj.com/content/12/4/e057335)\n.\n54 Specchia ML, Frisicale EM, Carini E, Di Pilla A, Cappa D, Barbara A, Ricciardi W, Damiani G. The impact of tumor board on cancer care: evidence from an umbrella review. BMC Health Serv Res 2020;20(1):73.\n58 Saunders C. The treatment of intractable pain in terminal cancer. Proc R Soc Med 1963;56(3):195-7.\n59 Cicely Sauders Nursing Mirror 1964; 14 February: pp vii-x.\n60 Ferris FD, Bruera E, Cherny N, Cummings C, Currow D, Dudgeon D, Janjan N, Strasser F, von Gunten CF, Von Roenn JH. Palliative cancer care a decade later: accomplishments, the need, next steps -- from the American Society of Clinical Oncology. J Clin Oncol 2009;27(18):3052-8.\n61 Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 2010;363(8):733-42.\n62 Hoerger M, Greer JA, Jackson VA, Park ER, Pirl WF, El-Jawahri A, Gallagher ER, Hagan T, Jacobsen J, Perry LM, Temel JS. Defining the Elements of Early Palliative Care That Are Associated With Patient-Reported Outcomes and the Delivery of End-of-Life Care. J Clin Oncol 2018;36(11):1096-1102.\n63 Kavalieratos D, Corbelli J, Zhang D, Dionne-Odom JN, Ernecoff NC, Hanmer J, Hoydich ZP, Ikejiani DZ, Klein-Fedyshin M, Zimmermann C, Morton SC, Arnold RM, Heller L, Schenker Y. Association Between Palliative Care and Patient and Caregiver Outcomes: A Systematic Review and Meta-analysis. JAMA 2016;316(20):2104-2114.\n64 Haun MW, Estel S, R\u00fccker G, Friederich HC, Villalobos M, Thomas M, Hartmann M. Early palliative care for adults with advanced cancer. Cochrane Database Syst Rev 2017;6(6):CD011129.\n65 Hui D, Kim YJ, Park JC, Zhang Y, Strasser F, Cherny N, Kaasa S, Davis MP, Bruera E. Integration of oncology and palliative care: a systematic review. Oncologist 2015;20(1):77-83.\n66 Hui D, Bansal S, Strasser F, Morita T, Caraceni A, Davis M, Cherny N, Kaasa S, Currow D, Abernethy A, Nekolaichuk C, Bruera E. Indicators of integration of oncology and palliative care programs: an international consensus. Ann Oncol 2015;26(9):1953-1959.\n67 Davis MP, Strasser F, Cherny N. How well is palliative care integrated into cancer care? A MASCC, ESMO, and EAPC Project. Support Care Cancer 2015;23(9):2677-85.\n68 Hui D, Meng YC, Bruera S, Geng Y, Hutchins R, Mori M, Strasser F, Bruera E. Referral Criteria for Outpatient Palliative Cancer Care: A Systematic Review. Oncologist 2016;21(7):895-901.\n69 Hui D, Mori M, Watanabe SM, Caraceni A, Strasser F, Saarto T, Cherny N, Glare P, Kaasa S, Bruera E. Referral criteria for outpatient specialty palliative cancer care: an international consensus. Lancet Oncol 2016;17(12):e552-e559.\n70 Hui D, Mori M, Meng YC, Watanabe SM, Caraceni A, Strasser F, Saarto T, Cherny N, Glare P, Kaasa S, Bruera E. Automatic referral to standardize palliative care access: an international Delphi survey. Support Care Cancer 2018;26(1):175-180.\n71 Hui D, Cherny NI, Wu J, Liu D, Latino NJ, Strasser F. Indicators of integration at ESMO Designated Centres of Integrated Oncology and Palliative Care. ESMO Open 2018;3(5):e000372.\n72 Blum D, Seiler A, Schmidt E, Pavic M, Strasser F. Patterns of integrating palliative care into standard oncology in an early ESMO designated center: a 10-year experience. ESMO Open 2021;6(3):100147.\n75 Hui D, Cherny NI, Wu J, Liu D, Latino NJ, Strasser F. Indicators of integration at ESMO Designated Centres of Integrated Oncology and Palliative Care. ESMO Open 2018;3(5):e000372.\n76 Hui D, Cherny N, Latino N, Strasser F. The \u2018critical mass\u2019 survey of palliative care programme at ESMO designated centres of integrated oncology and palliative care. Ann Oncol 2017;28(9):2057-2066.\n79 Evidence from at least one large randomised, controlled trial of good methodological quality (low potential for bias) or meta-analyses of well- conducted randomised trials without heterogeneity (\n[https://www.esmo.org/guidelines/esmo-guidelines-methodology](https://www.esmo.org/guidelines/esmo-guidelines-methodology)\n).\n80 Small randomised trials or large randomised trials with a suspicion of bias (lower methodological quality) or meta-analyses of such trials or of trials with demonstrated heterogeneity (\n[https://www.esmo.org/guidelines/esmo-guidelines-methodology](https://www.esmo.org/guidelines/esmo-guidelines-methodology)\n).\n81 Kent DM, Steyerberg E, van Klaveren D. Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects. BMJ. 2018 Dec 10;363:k4245.\n82 McGettigan P, Ferner R. We need reliable evidence to guide treatment choices for the many, not the few. BMJ 2022;377:o1465. doi: 10.1136/bmj.o1465.\n83 Concato J, Corrigan-Curay J. Real-World Evidence \u2013 Where Are We Now? N Engl J Med 2022;386(18):1680-1682.\n[doi: 10.1056/NEJMp2200089](https://www.nejm.org/doi/full/10.1056/NEJMp2200089)\n.\n84 Gajra A, Zettler ME, Feinberg BA. Randomization versus Real-World Evidence. N Engl J Med 2020;383(4):e21.\n[doi: 10.1056/NEJMc2020020](https://www.nejm.org/doi/full/10.1056/NEJMc2020020)\n.\n85 Tricoci P, Allen JM, Kramer JM, et al. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA 2009;301(8):831-41.\n[doi: 10.1001/jama.2009.205](https://pubmed.ncbi.nlm.nih.gov/19244190/)\n.\n86 Poonacha TK, Go RS. Level of scientific evidence underlying recommendations arising from the National Comprehensive Cancer Network clinical practice guidelines. J Clin Oncol 2011;29(2):186-91.\n[doi: 10.1200/JCO.2010.31.6414](https://pubmed.ncbi.nlm.nih.gov/21149653/)\n.\n87 Arends J, Strasser F, Gonella S, et al; ESMO Guidelines Committee. Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines. ESMO Open 2021;6(3):100092.\n[doi: 10.1016/j.esmoop.2021.100092](https://www.esmo.org/guidelines/guidelines-by-topic/supportive-and-palliative-care/cancer-cachexia-in-adult-patients)\n.\n88 Yao L, Guyatt GH, Djulbegovic B. Can we trust strong recommendations based on low quality evidence? BMJ 2021;375:n2833.\n[doi: 10.1136/bmj.n2833](https://www.bmj.com/content/375/bmj.n2833)\n.\n89 Boutron I, Dutton S, Ravaud P, Altman DG. Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. JAMA 2010;303(20):2058-64.\n90 Jones CW, Keil LG, Holland WC, Caughey MC, Platts-Mills TF. Comparison of registered and published outcomes in randomized controlled trials: a systematic review. BMC Med 2015;13:282.\n91 Riveros C, Dechartres A, Perrodeau E, Haneef R, Boutron I, Ravaud P. Timing and completeness of trial results posted at ClinicalTrials.gov and published in journals. PLoS Med 2013;10(12):e1001566.\n92 Duyx B, Urlings MJE, Swaen GMH, Bouter LM, Zeegers MP. Scientific citations favor positive results: a systematic review and meta-analysis. J Clin Epidemiol 2017;88:92-101.\n93 Jureidini J, McHenry LB. The illusion of evidence based medicine. BMJ 2022;376:o702.\n[doi: 10.1136/bmj.o702](https://www.bmj.com/content/376/bmj.o702)\n.\n94 Ioannidis JP. Evidence-based medicine has been hijacked: a report to David Sackett. J Clin Epidemiol 2016;73:82-6.\n[doi: 10.1016/j.jclinepi.2016.02.012](https://pubmed.ncbi.nlm.nih.gov/26934549/)\n.\n95 Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hr\u00f3bjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinness LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71.\n96 Deml MJ, Dietrich LG, Wingeier B, Etter G, Gallmann C, Berger C, Suggs LS, Huber BM, Tarr PE. Collaborating with Complementary and Alternative Medicine (CAM) Providers When Writing HPV Vaccine Review Articles. J Clin Med 2020;9(2):592.\n97 Pence BW, Gaynes BN, Thielman NM, Heine A, Mugavero MJ, Turner EL, Quinlivan EB. Balancing Contamination and Referral Bias in a Randomized Clinical Trial: An Application of Pseudo-Cluster Randomization. Am J Epidemiol 2015;182(12):1039-46.\n98 Sussman JB, Hayward RA. An IV for the RCT: using instrumental variables to adjust for treatment contamination in randomised controlled trials. BMJ 2010;340:c2073.\n99 Rooshenas L, Elliott D, Wade J, Jepson M, Paramasivan S, Strong S, Wilson C, Beard D, Blazeby JM, Birtle A, Halliday A, Rogers CA, Stein R, Donovan JL; ACST-2 study group; By-Band-Sleeve study group; Chemorad study group; CSAW study group; Optima prelim study group; POUT study group. Conveying Equipoise during Recruitment for Clinical Trials: Qualitative Synthesis of Clinicians\u2019 Practices across Six Randomised Controlled Trials. PLoS Med 2016;13(10):e1002147.\n100 Kaptchuk TJ, Hemond CC, Miller FG. Placebos in chronic pain: evidence, theory, ethics, and use in clinical practice. BMJ 2020;370:m1668.\n[doi: 10.1136/bmj.m1668](https://www.bmj.com/content/370/bmj.m1668)\n.\n101 Hjermstad MJ, Aass N, Andersen S, et al. PALLiON \u2013 PALLiative care Integrated in ONcology: study protocol for a Norwegian national cluster-randomized control trial with a complex intervention of early integration of palliative care. Trials 2020;21(1):303. doi: 10.1186/s13063-020-4224-4.\n102 Renz M, Reichmuth O, Bueche D, Traichel B, Mao MS, Cerny T, Strasser F. Fear, Pain, Denial, and Spiritual Experiences in Dying Processes. Am J Hosp Palliat Care 2018;35(3):478-491.\n103 Kienle GS, Ben-Arye E, Berger B, et al. Contributing to Global Health: Development of a Consensus-Based Whole Systems Research Strategy for Anthroposophic Medicine. Evid Based Complement Alternat Med 2019;2019:3706143.\n[doi: 10.1155/2019/3706143](https://pubmed.ncbi.nlm.nih.gov/31781267/)\n.\n104 Baars EW, Kiene H, Kienle GS, et al. An assessment of the scientific status of anthroposophic medicine, applying criteria from the philosophy of science. Complement Ther Med. 2018 Oct;40:145-150.\n[doi: 10.1016/j.ctim.2018.04.010](https://www.sciencedirect.com/science/article/pii/S0965229917308804)\n.\n105 Baars EW, Kienle GS, Heusser P, Pedersen PA, van Wietmarschen HA, Kiene H, von Schoen-Angerer T, Hamre HJ. Anthroposophic Medicinal Products: A Literature Review of Features, Similarities and Differences to Conventional Medicinal Products, Scientific and Regulatory Assessment. Glob Adv Health Med 2022;11:21649561211073079.\n106 Baars EW, Kiene H, Kienle GS, Heusser P, Hamre HJ. An assessment of the scientific status of anthroposophic medicine, applying criteria from the philosophy of science. Complement Ther Med 2018;40:145-150.\n107 Steigenberger C, Flatscher-Thoeni M, Siebert U, Leiter AM. Determinants of willingness to pay for health services: a systematic review of contingent valuation studies. Eur J Health Econ 2022;23(9):1455-1482.\n108 Tilburt J, Yost KJ, Lenz HJ, et al. A Multicenter Comparison of Complementary and Alternative Medicine (CAM) Discussions in Oncology Care: The Role of Time, Patient-Centeredness, and Practice Context. Oncologist 2019;24(11):e1180-e1189.\n[doi: 10.1634/theoncologist.2019-0093](https://pubmed.ncbi.nlm.nih.gov/31101701/)\n.\n109 Bien DR, Danner M, Vennedey V, Civello D, Evers SM, Hiligsmann M. Patients\u2019 Preferences for Outcome, Process and Cost Attributes in Cancer Treatment: A Systematic Review of Discrete Choice Experiments. Patient 2017;10(5):553-565.\n110 Mangin D, Stephen G, Bismah V, Risdon C. Making patient values visible in healthcare: a systematic review of tools to assess patient treatment priorities and preferences in the context of multimorbidity. BMJ Open. 2016 Jun 10;6(6):e010903.", "language": null, "image": "https://saez.swisshealthweb.ch/fileadmin/_processed_/6/c/csm_24_Teaser_Coverstory_1044x450px_73988c0253.jpg", "pagetype": "article", "links": ["https://www.swisshealthweb.ch/de/newsfeed/", "https://saez.swisshealthweb.ch/de/", "#collapseSearch", "/de/article/doi/saez.2023.21921/", "/fr/article/doi/bms.2023.21921/", "https://www.swisshealthweb.ch/de/newsfeed/", "https://saez.swisshealthweb.ch/de/", "/de/", "/de/aktuelle-ausgabe/", "/de/archiv/", "/de/publizieren/", "/de/ueber-saez/", "https://www.swisshealthweb.ch/de/zeitschriften/", "https://shop.emh.ch/", "https://www.swisshealthweb.ch/de/encyclomed/", "https://events.emh.ch", "https://saez.swisshealthweb.ch/de/article/?tx_cs2services_teaser%5Baction%5D=serviceLinkHandler&tx_cs2services_teaser%5Bcontroller%5D=Services&tx_cs2services_teaser%5Bservice%5D=9&type=96529&cHash=712c3da46ac560374a1cc72a483b3efd", "https://jobs.saez.ch/de", "https://market.swisshealthweb.ch/de/", null, "tel:+410614678555", "#", "https://www.swisshealthweb.ch/de/newsfeed/", "/de/article/doi/saez.2023.21921/", "/fr/article/doi/bms.2023.21921/", "https://events.emh.ch/", "https://jobs.saez.ch/de", "https://market.swisshealthweb.ch/de/", "https://shop.emh.ch/", null, "/de/selected-filter/attribute/FMH/", "javascript:void(0)", "https://saez.swisshealthweb.ch/fileadmin/assets/SAEZ/2023/saez.2023.21921/saez-2023-21921.pdf", "/de/selected-filter/attribute/FMH/", "#otherInfos", "/de/archiv/ausgabe/issue-doi/saez.2023.24/", "https://doi.org/10.4414/saez.2023.21921", "javascript:void(0)", "https://saez.swisshealthweb.ch/fileadmin/assets/SAEZ/2023/saez.2023.21921/saez-2023-21921.pdf", "https://pubmed.ncbi.nlm.nih.gov/31672502/", "https://pubmed.ncbi.nlm.nih.gov/35280471/", "https://www.nobelprize.org/prizes/medicine/2017/press-release/", "https://www.hufelandgesellschaft.de/forschung-integrative-medizin/evidenz#c682", "https://www.cochrane.de/ueber-uns/evidenzbasierte-medizin", "https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-020-01311-y", "https://bmjopen.bmj.com/content/12/4/e057335", "https://www.krebsliga.ch/beratung-unterstuetzung/fachpersonen/q-label/qualitaetslabel-fuer-brustzentren/zertifizierte-zentren", "https://www.chuv.ch/fileadmin/sites/dso/documents/Congres_SCHP_1.09.Care-Board_CD.pdf", "https://www.oncoreha.ch/", "https://www.siwf.ch/files/pdf7/medizinische_onkologie_version_internet_d.pdf", "https://www.esmo.org/about-esmo/organisational-structure/educational-committee/designated-centres-working-group", "https://www.siwf.ch/files/pdf17/palliativmedizin_version_internet_d.pdf", "https://www.unioncomed.ch/", "https://www.esmo.org/guidelines/esmo-guidelines-methodology", "https://www.esmo.org/guidelines/esmo-guidelines-methodology", "https://www.nejm.org/doi/full/10.1056/NEJMp2200089", "https://www.nejm.org/doi/full/10.1056/NEJMc2020020", "https://pubmed.ncbi.nlm.nih.gov/19244190/", "https://pubmed.ncbi.nlm.nih.gov/21149653/", "https://www.esmo.org/guidelines/guidelines-by-topic/supportive-and-palliative-care/cancer-cachexia-in-adult-patients", "https://www.bmj.com/content/375/bmj.n2833", "https://www.bmj.com/content/376/bmj.o702", "https://pubmed.ncbi.nlm.nih.gov/26934549/", "https://www.bmj.com/content/370/bmj.m1668", "https://pubmed.ncbi.nlm.nih.gov/31781267/", "https://www.sciencedirect.com/science/article/pii/S0965229917308804", "https://pubmed.ncbi.nlm.nih.gov/31101701/", "https://emh.ch/en/emh/rights-and-licences/", "#top", null, null, "tel:+410614678555", "#", "https://www.swisshealthweb.ch/de/newsfeed/", "https://www.swisshealthweb.ch/de/informationen-und-services/qualitaetssicherung/", "https://www.swisshealthweb.ch/de/informationen-und-services/publizistische-leitlinien/", "https://www.swisshealthweb.ch/de/informationen-und-services/copyright/", "https://www.swisshealthweb.ch/de/informationen-und-services/newsletter/", "https://www.swisshealthweb.ch/de/verlag/ueber-emh/", "https://www.swisshealthweb.ch/de/verlag/inserieren/", "https://www.swisshealthweb.ch/de/verlag/jobs/", "https://www.swisshealthweb.ch/de/partner/", "https://www.swisshealthweb.ch/de/verlag/hilfe-und-kontakt/", "https://www.swisshealthweb.ch/de/agb/", "https://www.swisshealthweb.ch/de/verlag/impressum/", "https://www.swisshealthweb.ch/de/verlag/datenschutz/", "https://www.swisshealthweb.ch/de/verlag/disclaimer/", "javascript:void()"]}